CIK 0001736730 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Camp4 Therapeutics Corp
Sign in to watch- Ticker
- CAMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-651-8867
- Business address
- 100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4/A Open-market buy 10% owner bought 909,090 shares at $11.00 ($9,999,990)
- 3/A Insider 3/A
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 763,636 shares at $11.00 ($8,399,996)
- 4 Open-market buy 10% owner bought 727,272 shares at $11.00 ($7,999,992)
- 4 Open-market buy 10% owner bought 1,363,636 shares at $11.00 ($14,999,996)
Page 7 of 10 · 193 filings